-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

905.O4.6 905. Outcomes Research—Lymphoid Malignancies: Patient Representation and Equity in Hematologic Malignancies

Symposia: Outcomes Research—Lymphoid Malignancies Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical Practice (Health Services and Quality), health outcomes research, Clinical Research, health disparities research, Diversity, Equity, and Inclusion (DEI) , Diseases, real-world evidence, Lymphoid Malignancies, survivorship
Saturday, December 10, 2022: 4:00 PM-5:30 PM
208-210 (Ernest N. Morial Convention Center)
Moderators:
Ghulam Rehman Mohyuddin, MD, University of Utah Health and Raul Cordoba, MD, PhD, Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD
Disclosures:
No relevant conflicts of interest to declare.
This session discusses the outcomes as it related to vulnerable populations such as elderly and people of color.
4:00 PM

Demi T.C. de Winter, MD1*, Jenneke E. Van Atteveld, MD1*, Vincent G. Pluimakers, MD1*, Marta Fiocco, Prof. PhD1,2,3*, Rutger A.J. Nievelstein, MD1,4*, Monique G.G. Hobbelink, MD4*, Andrica C.H. de Vries, MD1,5, Jacqueline J. Loonen, MD6*, Eline Van Dulmen-den Broeder, PhD7*, Helena J. van der Pal, MD1*, Saskia M.F. Pluijm, PhD1*, Leontien C.M. Kremer, PhD1,7,8*, Cécile M. Ronckers, PhD1*, Margriet van der Heiden-van der Loo, PhD1,9*, Birgitta Versluys, MD1*, Marloes Louwerens, MD10*, Dorine Bresters, MD1,11*, Hanneke M. van Santen, MD1,12*, Daniel S. Olsson, MD13*, Imo Hoefer, MD14*, Sjoerd A.A. van den Berg, PhD15,16*, Jaap den Hartogh, MA17*, Wim J.E. Tissing, MD1,18*, Sebastian J.C.M.M. Neggers, MD1,16* and Marry M. van den Heuvel-Eibrink, MD1,5,19

1Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
2Mathematical Institute, Leiden University, Leiden, Netherlands
3Medical Statistics Section, Department of Biomedical Data Science, Leiden University Medical Center, Leiden, Netherlands
4Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, Netherlands
5Department of Pediatric Oncology, Sophia Children’s Hospital, Erasmus Medical Center, Rotterdam, Netherlands
6Department of Hematology, Radboud University Medical Center, Nijmegen, Netherlands
7Department of Pediatric Oncology, Emma Children’s Hospital, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
8Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands
9Dutch Childhood Oncology Group, Utrecht, Netherlands
10Department of Internal Medicine, Leiden University Medical Center, Leiden, Netherlands
11Department of Pediatrics, Willem Alexander Children’s Hospital, Leiden University Medical Center, Leiden, Netherlands
12Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands
13Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, 405 30 Gothenburg, Sweden
14Central Diagnostic Laboratory, University Medical Center Utrecht, Utrecht, Netherlands
15Department of Clinical Chemistry, Erasmus Medical Center, Rotterdam, Netherlands
16Department of Internal Medicine, section Endocrinology, Erasmus Medical Center, Rotterdam, Netherlands
17Dutch Childhood Cancer Organisation, De Bilt, Netherlands
18Deparment of Pediatric Oncology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
19Division of Child Health, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands

4:15 PM

Shakira J. Grant, MBBS1,2, Milenka Jean-Baptiste, MPH3*, Mykela Moore, BA3*, Jiona Mills, BSPH3*, Lauren Bates, MA4*, Sascha A. Tuchman, MD, MHS1,2 and Paul Mihas, MA5*

1Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC
2Department of Medicine, Division of Hematology, The University of North Carolina at Chapel Hill, Chapel Hill, NC
3Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC
4Department of Allied Health Sciences, The University of North Carolina at Chapel Hill, Chapel Hill, NC
5Odum Institute for Research in Social Sciences, The University of North Carolina at Chapel Hill, Chapel Hill, NC

4:30 PM

Andrew Hantel, MD1,2, Marlise R. Luskin, MD3, Timothy R. Rebbeck, PhD3,4*, Andrew M. Brunner, MD5, Dillon D. Clancy, BA6*, Richard M. Stone, MD7, Daniel J DeAngelo, MD, PhD7, Christopher S. Lathan, MD, MS, MPH8* and Gregory A. Abel, MD, MPH9

1Center for Bioethics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
2HMS Center for Bioethics, Dana-Farber Cancer Institute, Boston, MA
3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
4Harvard T.H. Chan School of Public Health, Boston, MA
5Mass General Cancer Center, Massachusetts General Hospital, Boston, MA
6Dana-Farber Cancer Institute, Boston, MA
7Center for Leukemia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
8Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA
9Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

4:45 PM

Kristine Karvonen, MD1,2, Erin Balay-Dustrude, MD3*, Annie Do, MPH4,5,6*, Miranda Bradford, MS2,7*, Amanda Phipps, PhD, MPH5,8* and Abby R. Rosenberg, MD, MS, MA2,9*

1Department of Pediatrics, Division of Hematology/Oncology, University of Washington School of Medicine, SEATTLE, WA
2Seattle Children’s Research Institute, Palliative Care and Resilience Program, Seattle, WA
3Division of Rheumatology, Department of Pediatrics, University of Washington School of Medicine, University of Washington, Seattle, WA
4Department of Health Systems and Population Health, University of Washington School of Public Health, University of Washington, Seattle, WA
5Department of Epidemiology, University of Washington School of Public Health, University of Washington, Seattle, WA
6Health Economics and Outcomes Research, CHOICE Institute, University of Washington School of Pharmacy, University of Washington, Seattle, WA
7Seattle Children’s Research Institute, Core for Biostatistics, Epidemiology, and Analytics in Research, Seattle, WA
8Fred Hutchinson Cancer Center, Public Health Sciences Division, Seattle, WA
9Department of Pediatrics, Division of Hematology/Oncology, University of Washington School of Medicine, Seattle, WA

5:00 PM

Shakira J. Grant, MBBS1,2, Milenka Jean-Baptiste, MPH3*, Mykela Moore, BA3*, Jiona Mills, BSPH3*, Lauren Bates, MA4*, Sascha A. Tuchman, MD, MHS1,5 and Paul Mihas, MA6*

1Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC
2Department of Medicine, Division of Hematology, The University of North Carolina at Chapel Hill, Chapel Hill, NC
3Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC
4Department of Allied Health Sciences, The University of North Carolina at Chapel Hill, Chapel Hill, NC
5Division of Hematology, The University of North Carolina at Chapel Hill, Chapel Hill, NC
6Odum Institute for Research in Social Sciences, The University of North Carolina at Chapel Hill, Chapel Hill, NC

5:15 PM

Dee Lin1*, Yihang Liu2*, Nina Kim1*, Savanna Ledford1*, Aerin Sun2*, Kimberly Brunisholz1*, Rohan Medhekar1*, Lisa Abramovitz2*, Keshia Maughn2*, Victor Johnson2*, Michael Schultz2* and Bingcao Wu1*

1Real World Value and Evidence, Janssen Scientific Affairs, LLC, Horsham, PA
2Real World Evidence, STATinMED, Dallas, TX

*signifies non-member of ASH